Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Disposition to Issuer of 219,561 ADXN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Addex Therapeutics Ltd. (ADXN) | Disposition to Issuer | 219,561 | n/a |
| Jul 2, 2026 | Q32 Bio Inc. (QTTB) | Exercise/Conversion | 53,521 | $149.9K |
| Jun 16, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 9,810 | n/a |
| Jan 2, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 5,258 | n/a |
| Oct 28, 2025 | Q32 Bio Inc. (QTTB) | Grant/Award | 53,521 | n/a |
| Oct 2, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 5,545 | n/a |
| Jul 2, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 6,311 | n/a |
| May 30, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 7,650 | n/a |
| Apr 2, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 3,469 | n/a |
| Feb 27, 2025 | Q32 Bio Inc. (QTTB) | Disposition to Issuer | 12,767 | n/a |